Cargando…
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the ERK pathway
Ovarian cancer is one of the most common causes of death from gynecologic tumors and is an important public health issue. Ghrelin is a recently discovered bioactive peptide that acts as a natural endogenous ligand of the growth hormone secretagogue receptor (GHSR). Several studies have identified th...
Autores principales: | Bai, R.X., Wang, W.P., Zhao, P.W., Li, C.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763821/ https://www.ncbi.nlm.nih.gov/pubmed/26840702 http://dx.doi.org/10.1590/1414-431X20155043 |
Ejemplares similares
-
Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
por: Leng, Yun, et al.
Publicado: (2021) -
Invasiveness of mouse embryos to human ovarian cancer cells HO8910PM and the role of MMP-9
por: Ding, Xiaoyan, et al.
Publicado: (2012) -
Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro
por: Dong, Pei-Xin, et al.
Publicado: (2008) -
Effect of 3`-Azido-3`-Deoxythymidine (AZT) on Telomerase Activity and Proliferation of HO-8910 Cell Line of Ovarian Cancer
por: Dinman, Jonathan D.
Publicado: (2006) -
Effect of 3`-Azido-3`-Deoxythymidine (AZT) on Telomerase Activity and Proliferation of HO-8910 Cell Line of Ovarian Cancer
por: Li, Hongmei, et al.
Publicado: (2006)